Peter Gimsing
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 84
- Multiple Myeloma Research and Treatments 77
-
- Protein Degradation and Inhibitors 19
- Amyloidosis: Diagnosis, Treatment, Outcomes 10
- Histone Deacetylase Inhibitors Research 9
- Cancer therapeutics and mechanisms 8
- Co-authors
- Lene Meldgaard Knudsen (13 shared papers)Annette Juul Vangsted (27 shared papers)Ingemar Turesson (14 shared papers)Erik Hippe (15 shared papers)Konstantinos Dimopoulos (4 shared papers)Kirsten Grønbæk (4 shared papers)Niels Abildgaard (27 shared papers)Tobias Wirenfeldt Klausen (23 shared papers)
In The Last Decade
Peter Gimsing
111 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 95
- Hematology 2.1k
- Oncology 1.1k
- Molecular Biology 1.6k
- Genetics 235
- Rheumatology 219
Countries citing papers authored by Peter Gimsing
This map shows the geographic impact of Peter Gimsing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gimsing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gimsing more than expected).
Fields of papers citing papers by Peter Gimsing
This network shows the impact of papers produced by Peter Gimsing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gimsing. The network helps show where Peter Gimsing may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Gimsing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 266 | |
| 2 | 2011 | 194 | |
| 3 | 2010 | 194 | |
| 4 | 2007 | 184 | |
| 5 | 2008 | 147 | |
| 6 | 2014 | 106 | |
| 7 | 2005 | 97 | |
| 8 | 1998 | 88 | |
| 9 | 2001 | 74 | |
| 10 | 1999 | 69 | |
| 11 | 2017 | 67 | |
| 12 | 2012 | 55 | |
| 13 | 99mTc-aprotinin scintigraphy in amyloidosis. | 2003 | 55 |
| 14 | 2006 | 55 | |
| 15 | Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation. | 2006 | 52 |
| 16 | 2015 | 48 | |
| 17 | 2016 | 47 | |
| 18 | 2006 | 45 | |
| 19 | 2015 | 43 | |
| 20 | 2013 | 42 |
About Peter Gimsing
Peter Gimsing is a scholar working on Hematology, Molecular Biology, Oncology, Rheumatology and Genetics, having authored 112 papers that have together received 3.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (77 papers), Protein Degradation and Inhibitors (19 papers), Cancer Treatment and Pharmacology (19 papers), Folate and B Vitamins Research (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Histone Deacetylase Inhibitors Research (9 papers), Peptidase Inhibition and Analysis (8 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Hematology (2.1k citations), Oncology (1.1k citations), Molecular Biology (1.6k citations), Genetics (235 citations) and Rheumatology (219 citations). Peter Gimsing has collaborated with scholars based in Denmark, Sweden and Norway. Frequent co-authors include Lene Meldgaard Knudsen, Annette Juul Vangsted, Ingemar Turesson, Erik Hippe, Konstantinos Dimopoulos, Kirsten Grønbæk, Niels Abildgaard, Tobias Wirenfeldt Klausen, Hans Erik Johnsen and Ebba Nexø. Their work appears in journals such as Blood, European Journal Of Haematology, British Journal of Haematology, Journal of Clinical Oncology and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.